Citing Liver Damage, Pfizer Withdraws Thelin

NEW YORK - (AP) Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage . Thelin is sold in the European Union, Canada, and Australia as an oral treatment for severe pulmonary arterial hypertension...